Li, Chunyan <br/><br/>
SPAG9 May Be a Potential Prognostic Marker of Endometrial Hyperplasia and Grade 1 Endometrioid Adenocarcinoma Treated with Progestin.  [electronic resource] 

 -  Gynecologic and obstetric investigation  2016 
 - 267-74 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1423-002X 
<br/><br/><label>Standard No.: </label>10.1159/000437015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--analysis<br/>Adult<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Blotting, Western<br/>Carcinoma, Endometrioid--diagnosis<br/>Cell Line, Tumor<br/>Early Detection of Cancer--methods<br/>Endometrial Hyperplasia--diagnosis<br/>Endometrial Neoplasms--diagnosis<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Medroxyprogesterone Acetate--therapeutic use<br/>Prognosis<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction